<DOC>
	<DOC>NCT02701816</DOC>
	<brief_summary>- Prospective, single-arm, multi-center registry study - A total of 150 subjects with femoropopliteal artery disease who meet all inclusion and exclusion criteria will be included. - Patients will be followed clinically for 12 months after the procedure. - Duplex ultrasound, CT or catheter-based angiography follow-up according to participating hospital's protocol will be performed at 12 months. - Presence of stent fracture will be evaluated by plain radiography or fluoroscopy at 12 months. - Quality of life by standardized questionnaires (at baseline &amp; at 1 &amp; 12 months)</brief_summary>
	<brief_title>Korean Multicenter Registry of INNOVA Stent for Femoropopliteal Artery Disease: (K-INNOVA Registry)</brief_title>
	<detailed_description />
	<criteria>1. Age 19 years of older 2. Symptomatic peripheral artery disease: Moderate or severe claudication (Rutherford category 2 or 3) Critical limb ischemia (Rutherford category 45) 3. Femoropopliteal artery lesions with stenosis &gt; 50% 4. ABI &lt; 0.9 5. Patients with signed informed consent 1. Acute critical limb ischemia 2. Severe critical limb ischemia (Rutherford category 6) 3. Known hypersensitivity or contraindication to any of the following medications: heparin, aspirin, clopidogrel, cilostazol, or contrast agents 4. Instent restenosis lesions (Restenosis lesions without previously implanted stents are eligible to the enrollment) 5. Bypass graft lesions 6. Age &gt; 85 years 7. Severe hepatic dysfunction (&gt; 3 times normal reference values) 8. Significant leucopenia, neutropenia, thrombocytopenia, anemia, or known bleeding diathesis 9. LVEF &lt; 40% or clinically overt congestive heart failure 10. Pregnant women or women with potential childbearing 11. Life expectancy &lt;1 year due to comorbidity 12. Untreated proximal inflow disease of the ipsilateral iliac arteries (more than 50% stenosis or occlusion)</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Peripheral Artery Disease</keyword>
	<keyword>Femoropopliteal Artery</keyword>
	<keyword>Nitinol Stent</keyword>
	<keyword>Restenosis</keyword>
</DOC>